Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01701154 · ClinicalTrials.gov registry record

The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease

A clinical trial, sponsored by Duke University.

Completed
Registry status
11
Enrollment target

NCT01701154: Completed study, sponsored by Duke University.

NCT01701154 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01701154 has completed, sponsored by Duke University.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

The purpose of the study is to determine if respiratory muscle strength training will be beneficial for inspiratory and expiratory muscle strength in adults and children with Pompe disease.

Primary Outcome

change from pre-test to post-test

Interventions

  • OTHER respiratory muscle strength training

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2010-12
Est. Completion 2012-12-15
Duke University

1,725 total trials

What the finished NCT01701154 record still lists

NCT01701154 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which respiratory muscle strength training is the first listed.

NCT01701154 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01701154 about?

NCT01701154 is a clinical study titled "The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease". The purpose of the study is to determine if respiratory muscle strength training will be beneficial for inspiratory and expiratory muscle strength in adults and children with Pompe disease.

What is the current status of trial NCT01701154?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2010-12. Estimated completion is 2012-12-15.

What interventions are being tested in trial NCT01701154?

The interventions under investigation include: respiratory muscle strength training (OTHER).

Who is sponsoring clinical trial NCT01701154?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01701154, the US trial registry maintained by the National Library of Medicine. NCT01701154 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.